Richard W. Rodriguez
Under CEO Alexander Kunz, OP2 Labs has grown into a global nutritional supplement manufacturer known for innovation, resilience, and profitability. Despite challenges from the pandemic and inflation, the company achieved 130% revenue growth from 2022–23, with projections of another significant jump this year. “We are in growth mode,” says Kunz of investing more in customer acquisition and shoring up the company’s inventory position. Despite that, “we’ve been able to maintain a profitable, lean cost structure.”